» Articles » PMID: 21256905

Synergistic Steatohepatitis by Moderate Obesity and Alcohol in Mice Despite Increased Adiponectin and P-AMPK

Overview
Journal J Hepatol
Publisher Elsevier
Specialty Gastroenterology
Date 2011 Jan 25
PMID 21256905
Citations 78
Authors
Affiliations
Soon will be listed here.
Abstract

Background & Aims: Mechanisms underlying synergistic liver injury caused by alcohol and obesity are not clear. We have produced a mouse model of synergistic steatohepatitis by recapitulating the natural history of the synergism seen in patients for mechanistic studies.

Methods: Moderate obesity was induced in mice by 170% overnutrition in calories using intragastric overfeeding of high fat diet. Alcohol (low or high dose) was then co-administrated to determine its effects.

Results: Moderate obesity plus alcohol intake causes synergistic steatohepatitis in an alcohol dose-dependent manner. A heightened synergism is observed when a high alcohol dose (32g/kg/d) is used, resulting in plasma ALT reaching 392±28U/L, severe steatohepatitis with pericellular fibrosis, marked M1 macrophage activation, a 40-fold induction of iNos, and intensified nitrosative stress in the liver. Hepatic expression of genes for mitochondrial biogenesis and metabolism are significantly downregulated, and hepatic ATP level is decreased. Synergistic ER stress evident by elevated XBP-1, GRP78 and CHOP is accompanied by hyperhomocysteinemia. Despite increased caspase 3/7 cleavage, their activities are decreased in a redox-dependent manner. Neither increased PARP cleavage nor TUNEL positive hepatocytes are found, suggesting a shift of apoptosis to necrosis. Surprisingly, the synergism mice have increased plasma adiponectin and hepatic p-AMPK, but adiponectin resistance is shown downstream of p-AMPK.

Conclusions: Nitrosative stress mediated by M1 macrophage activation, adiponectin resistance, and accentuated ER and mitochondrial stress underlie potential mechanisms for synergistic steatohepatitis caused by moderate obesity and alcohol.

Citing Articles

MetALD: Clinical aspects, pathophysiology and treatment.

Gratacos-Gines J, Arino S, Sancho-Bru P, Bataller R, Pose E JHEP Rep. 2025; 7(2):101250.

PMID: 39897615 PMC: 11782861. DOI: 10.1016/j.jhepr.2024.101250.


Understanding the Role of Alcohol in Metabolic Dysfunction and Male Infertility.

Genchi V, Cignarelli A, Sansone A, Yannas D, Dalla Valentina L, Renda Livraghi D Metabolites. 2024; 14(11).

PMID: 39590862 PMC: 11596383. DOI: 10.3390/metabo14110626.


Waist-hip ratio is superior to BMI in predicting liver-related outcomes and synergizes with harmful alcohol use.

Aberg F, Farkkila M, Salomaa V, Jula A, Mannisto S, Perola M Commun Med (Lond). 2023; 3(1):119.

PMID: 37674006 PMC: 10482890. DOI: 10.1038/s43856-023-00353-2.


The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease.

Diaz L, Arab J, Louvet A, Bataller R, Arrese M Nat Rev Gastroenterol Hepatol. 2023; 20(12):764-783.

PMID: 37582985 DOI: 10.1038/s41575-023-00822-y.


Concomitant western diet and chronic-binge alcohol dysregulate hepatic metabolism.

Buyco D, Dempsey J, Scorletti E, Jeon S, Lin C, Harkin J PLoS One. 2023; 18(5):e0281954.

PMID: 37134024 PMC: 10155975. DOI: 10.1371/journal.pone.0281954.


References
1.
Mantena S, King A, Andringa K, Eccleston H, Bailey S . Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases. Free Radic Biol Med. 2008; 44(7):1259-72. PMC: 2323912. DOI: 10.1016/j.freeradbiomed.2007.12.029. View

2.
Moon K, Hood B, Kim B, Hardwick J, Conrads T, Veenstra T . Inactivation of oxidized and S-nitrosylated mitochondrial proteins in alcoholic fatty liver of rats. Hepatology. 2006; 44(5):1218-30. DOI: 10.1002/hep.21372. View

3.
Yuan J, Govindarajan S, Arakawa K, Yu M . Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S. Cancer. 2004; 101(5):1009-17. DOI: 10.1002/cncr.20427. View

4.
Ogden C, Carroll M, Curtin L, McDowell M, Tabak C, Flegal K . Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006; 295(13):1549-55. DOI: 10.1001/jama.295.13.1549. View

5.
Nielsen F, Mikkelsen B, Nielsen J, Andersen H, Grandjean P . Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clin Chem. 1997; 43(7):1209-14. View